RxDoctor Payments Data

David Hesse, MD

Urology · New Haven, CTNPI 1952343741

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,142 of the $4,001 with a category attached, or 78.5%. Covidien LP accounts for 78.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $3,142 and has fallen 95.9% since, to $128 in 2025.

$4,001in general payments, 2019–2025

Across 11 payments — averaging $363.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$3K
  • Palette Life Sciences, Inc.$244
  • Intuitive Surgical$193
  • Urogen Pharma, Inc.$156
  • Boston Scientific$138
  • Johnson & Johnson$128

What the payments were for

  • Consulting fees$3,14279%
  • Travel & lodging$1935%
  • Food & beverage$66117%
  • Education$50%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,001 in reported general payments places this provider in the 65th percentile of 156 urology providers in Connecticut.

See all urology providers in Connecticut

Medicare billing

Part B allowed, 2024
$111,008
Medicare patients
445
Services billed
1,182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron43$49,732
GemtesaVibegron13$6,347
Alfuzosin Hcl ErAlfuzosin Hcl268$6,008
Methenamine Hippurate37$5,782
Tamsulosin Hcl407$5,694
Tadalafil28$4,481
Finasteride307$4,170
Trospium Chloride32$2,364
Oxybutynin Chloride ErOxybutynin Chloride73$2,021
Dutasteride55$1,380
Silodosin24$1,074
Testosterone12$949
Imipramine Hcl39$729
Bicalutamide26$684
Allopurinol22$333

Paid to pharmacies, not to this prescriber.

Other urology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →